Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New beta 2-adrenergic agonist aerosols.

H W Kelly

    Clinical Pharmacy
    |July 1, 1985
    PubMed
    Summary

    Newer beta 2-adrenergic agonists like fenoterol and bitolterol offer no significant advantages over older agents. Optimal use of these asthma medications requires understanding dose-response and delivery methods for effective bronchodilation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

    The New England journal of medicine·2016
    Same author

    A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.

    The pharmacogenomics journal·2016
    Same author

    Updates on the use of inhaled corticosteroids in asthma.

    Current opinion in allergy and clinical immunology·2011
    Same author

    Evaluation of particle size distribution of salmeterol administered via metered-dose inhaler with and without valved holding chambers.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2002
    Same author

    Newness of drugs and use of HMO services by asthma patients.

    The Annals of pharmacotherapy·2001
    Same author

    Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma.

    Pediatric pulmonology·2000

    Area of Science:

    • Pharmacology
    • Respiratory Medicine

    Background:

    • Beta 2-adrenergic agonists are crucial for managing respiratory conditions.
    • Understanding their dose-response and delivery is key for effective treatment.

    Purpose of the Study:

    • To review the dose-response characteristics of beta 2-adrenergic agonists.
    • To compare newer agents (fenoterol, bitolterol) with older ones.

    Main Methods:

    • Literature review of beta 2-adrenergic agonist studies.
    • Analysis of dose-response, efficacy, and delivery systems.

    Main Results:

    • Fenoterol aerosol has a potent dose but no superior efficacy at equipotent doses.
    • Bitolterol is a prodrug with potential for improved bronchoselectivity, but human data is limited.
    • Tachycardia is a dose-limiting side effect for all agents.
    • Newer agents show no significant improvement in duration of action over terbutaline or albuterol.

    Conclusions:

    • Aerosol administration enhances bronchoselectivity for all beta 2-adrenergic agonists.
    • Optimal use depends on understanding dose-response and delivery variables.
    • Tube-spacer devices benefit patients with poor inhaler technique.
    • Albuterol and terbutaline are effective for exercise-induced bronchospasm prophylaxis.

    Related Experiment Videos